BioGenex Laboratories
Manufacturing · California, United States · 201-500 Employees
View Company Info for Free
Overview
Headquarters
48810 Kato Rd Ste 200E, Fremont, Califor...Phone Number
(510) 824-1400Website
www.biogenex.comRevenue
$62.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About BioGenex Laboratories
BioGenex S.R.L. designs, develops and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of the eFISHency integrated workflow solution for FISH laboratories and miRNA systems for the characterization of cancer of unknown primary (CUP) and for undifferentiated tumors is a game changer that has no rival in the industry. The company's fully automated molecular pathology workstations are the most advanced system globally. The customer-focused approach, with premier after-sales support and excellent technical service, provides the best-in-class customer care. The spirit of innovation drives us to deliver cutting-edge technology, years ahead of the competition, and the finest systems for life science research and diagnostics.Explore more
BioGenex Laboratories Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is BioGenex Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if BioGenex Laboratories had a recent Job posting/layoffs
Funding: Get notified immidiatlly once BioGenex Laboratories has new funding data
Check out if BioGenex Laboratories is spiking on competitors!
BioGenex Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Check if BioGenex Laboratories has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on BioGenex Laboratories recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at BioGenex Laboratories
Product Launch: Get notified when BioGenex Laboratories launches new products
Recommended Actions
Reach out to Masked Content who joined BioGenex Laboratories as Masked Content
Find 2 more new buyers
Compare Similar Companies to BioGenex Laboratories
Compare insights from companies similar to BioGenex Laboratories, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
BioGenex Laboratories
$62.7M
201-500
Private
<$5M
1981
EN
Elysabeth NguyenDirector, Commercial Operations
$7M
51-200
Private
$40.8M
2007
MS
Maithreyan SrinivasanTechnology Senior Director, Research & Development
Company Profile Activity
Activity Insights
BioGenex Laboratories is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
BioGenex Laboratories is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BioGenex Laboratories.
BioGenex Laboratories financials insights
Gather financial insights about BioGenex Laboratories, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
2021
Debt
$299K
BioGenex Laboratories Tech Stack
A closer look at the technologies used by BioGenex Laboratories
See more technologies
Most Recent Scoops
Open Position
Open Position
Open Position
Project
A mid-level source has indicated that the organization is investing in conversational intelligence tools.
Spending/Investment, Business Intelligence, Customer Engagement, Financial Planning, Customer Service
Project
Spending/Investment, Financial Planning
BioGenex Laboratories News & Media
Global Immunohistochemistry Market to Surpass US$ 2,448.93 Million by 2030, Says Coherent Market Insights (CMI)
Seattle, Oct. 10, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global immunohistochemistry market is estimated to be valued at US$ 1,463.69 million in 2022 and expected to exhibit a CAGR of 6.6 % over the forecast period (2022-2030).BioRegenx Announces Endothelial Glycocalyx Veterinary Study of Dogs and Cats Using the Testing Device GlycoCheck
CHATTANOOGA, TN, USA, September 28, 2022 /EINPresswire.com/ -- Microvascular Health Solutions, LLC (MVHS), a BioRegenx subsidiary based in Alpine, Utah, announces that a new peer-reviewed study has been published using GlycoCheck, a medical testing …Tissue Processing Systems Market to Reach US$ 493.76 Million by 2027- The Insight Partners
Rising Number of Diagnostic Laboratories is projected to Augment the Global Tissue Processing Systems Market - COVID-19 Impact and Global Analysis Rising Number of Diagnostic Laboratories is projected to Augment the Global Tissue Processing Systems Market - COVID-19 Impact and Global AnalysisAnatomic Pathology Market Revenue Continues to Dominate with CAGR Value Globally to 2027 : BioGenex Laboratories, Thermo Fisher Scientific, Hologic, Etc
New York, NY -- (SBWIRE) -- 11/26/2020 -- Anatomic Pathology Market report is to help the user to understand the Coronavirus (COVID19) Impact analysis on market in terms of its Definition, Segmentation, Market Potential, Influential Trends, and the Challenges that the Anatomic Pathology market is facing. Read the full press release at http://www.sbwire.com/press-releases/anatomic-pathology-market-revenue-continues-to-dominate-with-cagr-value-globally-to-2027-biogenex-laboratories-thermo-fisher-s
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding BioGenex Laboratories
Sign Up For FreeTo access detailed company insights
BioGenex S.R.L. designs, develops and commercializes advanced fully-automated molecular pathology systems for cancer diagnosis, prognosis, personalized medicine, and life science research. The recent introduction of the eFISHency integrated workflow solution for FISH laboratories and miRNA systems for the characterization of cancer of unknown prima... Read More
